Company CVAbout Fredun Pharmaceuticals Ltd 
Fredun Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations. Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL.
Company Coordinates
Company Details
26 Manoj Industrial Premises, G D Ambedkar Marg Wadala Mumbai Maharashtra : 400031
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 4.70 Cr
Number of Shares
46.99 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
05-Dec-2023
46.99
4.70
15000
10
Conversion of Warrants
22-Sep-2023
46.84
4.68
19072
10
Conversion of Warrants
14-Sep-2023
46.16
4.62
20800
10
Conversion of Warrants
14-Sep-2023
46.65
4.67
20800
10
Conversion of Warrants
23-Aug-2023
46.65
4.67
18068
10
Conversion of Warrants
23-Aug-2023
46.44
4.64
18068
10
Conversion of Warrants
10-Aug-2023
46.26
4.63
31100
10
Conversion of Warrants
02-Aug-2023
45.95
4.60
15000
10
Conversion of Warrants
02-May-2023
45.8
4.58
47850
10
Conversion of Warrants
21-Mar-2023
45.32
4.53
17500
10
Conversion of Warrants
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Daulat Nariman Medhora (29.88%)
Highest Public shareholder
Nikhil Kishorchandra Vora (6.38%)
Individual Investors Holdings
44.55%
Board of Directors
Management
Designation
Remuneration
Daulat N Medhora
Chairperson & Joint MD
12.0 lacs
Nariman B Medhora
Executive Director
2.2 lacs
Aspi N Raimalwala
Non-Exec. & Independent Dir.
54.67 k
Fredun N Medhora
Managing Director & CFO
40.8 lacs
Rohinton Kanga
Non-Exec. & Independent Dir.
54.67 k
Jinkal Shah
Company Sec. & Compli. Officer
41.9 k
Daisy Dsouza
Additional Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Service Income
2.40
4.13%
Service Income
Service Income
Stock DNARevenue and Profits:
Net Sales:
102 Cr
(Quarterly Results - Dec 2024)
Net Profit:
5 Cr
Pharmaceuticals & Drugs
INR 309 Cr (Micro Cap)
16.00
33
0.11%
0.86
15.67%
2.54
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
